Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT06736860

Recruiting

Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of Thromboelastography

Trauma Coagulopathy
NCT06428682

Recruiting

Role of TXA in Patients Undergoing Breast Free Flap Reconstruction

Breast Cancer | Blood Loss, Surgical
NCT06251648

Not yet recruiting

Acute Lymphoblastic Leukaemia Related to Lenalidomide (LenALL)

Cancer
NCT06152939

Not yet recruiting

Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention or Thrombolytic Therapy

Left Ventricular Thrombus
NCT05489185

Not yet recruiting

Clinical Trial to Assess the Efficacy of Tranexamic Acid in Reducing Blood Loss in Hip Fracture Patients.

Hip Fractures
NCT04178655

Not yet recruiting

Tranexamic Acid Effect on Digit Function Following Primary Repair of Traumatic Digit Flexor Tendon Injuries

Tendon Injury - Hand
NCT02538198

Active, not recruiting

Lenalidomide Maintenance in Plasma Cell Myeloma

Plasma Cell Myeloma
NCT06879353

Completed

Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery

Ovarian Cancer | Perioperative Blood Loss | Blood Transfusion Events
NCT02586727

Completed

Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy

Adverse Effect of Radiation Therapy
NCT01782443

Completed

Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors

Carcinoid Tumor
NCT03889249

Completed

Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke (AcT)

Stroke, Acute | Thromboses, Intracranial
NCT02559180

Completed

Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab (SwapTwo)

Diabetic Retinopathy | Macular Edema
NCT04331730

Completed

A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD (PHTHALO-205)

Neovascular Age-related Macular Degeneration
NCT02620748

Completed

Use of Intravenous Tranexamic Acid During Myomectomy (TA)

Fibroids | Hemorrhage/Blood Loss During Myomectomies
NCT04400799

Terminated

Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19

COVID-19 | Pulmonary Embolism, Deep Vein Thrombosis
NCT02611778

Completed

Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration (COLUMBUS-AMD)

Age-related Macular Degeneration (AMD)
NCT01455831

Completed

Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer (PERIOP-01)

Adenocarcinoma of the Colon
NCT04878835

Completed

Effects of Ranibizumab in Primary Pterygium Surgery

Patients With Primary Nasal Pterygium
NCT02032173

Terminated

Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase (CONSTELLATION)

Diabetes | Macular Degeneration | Macular Edema
NCT01306981

Completed

Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study (RaDiVit)

Diabetic Retinopathy | Retinal Neovascularisation
NCT04537533

Unknown

Tranexamic Acid Infusion in Low Dose Versus in High Dose for Reducing Blood Loss in Radical Cystectomy Operations

Bleeding
NCT02317549

Terminated

Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL)

Septic Shock
NCT04310631

Completed

Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab

Coats Disease
NCT02257294

Completed

A Trial of Low-dose Adjunctive alTeplase During prIMary PCI (T-TIME)

Myocardial Infarction
NCT01402544

Terminated

Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab (COMPASS)

Age-Related Macular Degeneration
NCT01908816

Completed

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. (ECLIPSE)

Diabetic Retinopathy | Macular Edema | Choroidal Neovascularization | Glaucoma, Neovascular
NCT01746420

Completed

Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis

Lateral Epicondylitis
NCT00952380

Completed

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Venous Thromboembolism
NCT00668785

Terminated

Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)

Macular Edema | Proliferative Diabetic Retinopathy
NCT00205374

Completed

Use of Cidofovir for Recurrent Respiratory Papillomatosis

Recurrent Respiratory Papillomatosis
NCT01972763

Completed

Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept. (RESCUE)

Recalcitrant Wet Age-related Macular Degeneration
NCT03218514

Completed

Venous Thromboprophylaxis in Bariatric Surgery (OBSUD)

Obesity
NCT00665652

Terminated

Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance (MGUS)

Neuropathy | Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)
NCT03059277

Withdrawn

Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab

Diabetic Macular Edema
NCT02219152

Unknown

Topical Instillation of Tranexamic Aacid in Bronchoscopy to Decrease Bleeding During Entobronchial & Transbronchial Biopsiy: a Prospective Double Blind Placebo Controlled Study

Bronchoscopy Biopsy
NCT02673879

Unknown

IMPI 2 - A Trial of Intrapericardial Alteplase in Large Pericardial Effusion (IMPI-2)

Pericardial Effusion
NCT03108807

Completed

National Early Warning Score and D-dimer to Identify Medical Patients at Low Risk of 30-day Mortality

Medical Patients in the Emergency Department
NCT01282242

Completed

A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients (MR WITNESS)

Acute Stroke
NCT01213667

Unknown

Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD (RESPONSE)

Macular Degeneration
NCT00036946

Completed

VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Lymphoma | Unspecified Adult Solid Tumor, Protocol Specific
NCT01037348

Completed

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen (REPAIR)

Choroidal Neovascularisation
NCT02733952

Unknown

Intravenous Tranexamic Acid Versus Pericervical Tourniquet To Decrease Blood Loss In Trans-Abdominal Myomectomy

Post Operative Hemorrhage
NCT01111903

Completed

A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse (REV)

Ovarian Cancer Recurrent
NCT00403039

Completed

Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema

Retinal Vein Occlusion
NCT00726466

Withdrawn

Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration (SEIRA)

Age Related Macular Degeneration | CNV | AMD
NCT00135863

Terminated

MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis

Inflammation | Peritoneal Dialysis | Nutrition
NCT01958164

Completed

Efficacy and Safety of Actilyse 2 mg/ 2 ml in Comparison to Saline Solution in Patients With Central Venous Access Device Occlusion

Vascular Access Devices | Catheter Obstruction
NCT01500915

Completed

FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration (FUSION)

Exudative Age-related Macular Degeneration
NCT02328209

Unknown

Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

Exudative Age-related Macular Degeneration
NCT02279186

Unknown

Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section

Bleeding

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations